Objective: To evaluate the effects of intraperitoneal instillation of lidocaine on postcesarean pain in patients with pariental periotoneal closure.
T wenty percent of chronic pain patients implicate surgery as 1 of the causes of their chronic pain and, in about half of them, it was the sole cause. 1 Recalling of severe acute postoperative pain was among the risk factors for development of chronic pain. 2 Recent reports showed the overall incidence of chronic postcesarean pain to vary between 12.3% 3 and 17.8%. 4 Strategies to reduce chronic postsurgical pain include resorting to minimally invasive surgical techniques to avoid nerve damage as laparoscopy instead of open surgery, nerve preservation and avoiding direct nerve compression during surgery, and the use of local anesthetics. 5 Bupivacaine bolus injections through intraoperative placed catheters at the end of abdominal hysterectomy, however, was as effective as saline injection in relieving postoperative pain. 6 Intraperitoneal 7 and perioperative intravenous 8 bupivacaine administration, immediately after the placement of trocars during laparoscopic cholecystectomy 7 or at the end of laparoscopic colectomy 8 effectively reduced the intensity of abdominal visceral pain 8 and was associated with lower analgesic need and earlier mobility. 7, 8 The same findings were reported with the use of or intraperitoneal lidocaine during gynecologic laparoscopy. 9, 10 In many centers around the world, pain relief after cesarean section is achieved through a multimodal approach, with either patient-controlled analgesia or neuraxial morphine in combination with other analgesics and local anesthetic techniques. 11 The use of local anesthetic techniques during cesarean, including wound infiltration and ilioinguinal iliohypogastric nerve blocks, succeeded in pain relief on the first postoperative day. 12 The Assiut University Women's Health Centre is an example of a tertiary medical center with a busy obstetric unit, serving some 12,000 deliveries per year, as a low-cost governorate sponsored medical service. The annual rate of cesarean section, as per department statistics in the year 2008, is around 23%. These facts make it impossible to provide a one-to-one attendance pain control service, because of the low care provider-to-patient ratio in our postoperative setting. Moreover, the limited medical resources and the fact that most of our patients are illiterates or have just passed school level education, make advanced pain control options as patient-controlled analgesia both unavailable and unpractical. In the light of this, the option of intraoperative use of preventive analgesia to reduce the incidence of postcesarean pain seems justifiable. Lidocaine is inexpensive, easy to administer, and relatively safe. 8 Intravenous lidocaine has analgesic 13 and antihyperalgesic 14 properties. Preliminary reports suggested that infusing local anesthetics in the intraperitoneal space, thereby blocking peritoneal afferents, may have a beneficial effect after gynecologic laparoscopic surgery. 9, 10 We therefore tested the hypothesis that intraperitoneal instillation of lidocaine can improve the incidence of postcesarean, acute, and chronic pain in patients with parietal peritoneal closure.
place from March 2007 through February 2008. Patients were eligible to participate in the study if they were early in labor, 37 weeks pregnant or more, indicated to undergo cesarean delivery without earlier scars from abdominal surgery, including earlier cesarean, and willing to participate in the study. Gestational age was determined on the basis of the last menstrual period, confirmed by an ultrasound between 14 and 20 weeks gestation and calculated in menstrual weeks. A written informed consent was obtained. Women were excluded if they had 1 of the following: being in the active phase of labor with cervical dilatation Z3 cm and/or uterine contractions of Z50 mm Hg measured by external tocodynamometer. Urinary tract infections diagnosed clinically before active labor and anemia as proved by venous sampling of hemoglobin percentage less than 10 gm/dL, served as exclusion criteria. Patients with psychologic disturbance, any form of chronic pain before or during pregnancy, indicated emergency cesarean section, receiving treatment for gastric symptoms or gastrointestinal tract trouble with pregnancy and failed spinal anesthesia were also excluded.
A secretary of the Statistics Unit at Assiut University Hospital generated a computer-based random allocation. The instructions to use intraperitoneal lidocaine or placebo (saline 0.9%) instillation were printed out and placed in sealed, opaque, consecutively numbered, and coded envelopes. Data collection sheets with corresponding codes were filled out preoperatively by the operating surgeon. After surgery, these sheets were completed by postoperative caregivers and residents. Just after providing consent, the women were given the next number on the random list, which corresponded to an envelope number, and were thus allocated to the control (placebo) group (group 1) or the lidocaine group (group 2). A number of syringes equal to the sample size were consecutively coded and prepared with the corresponding contents and stored under the appropriate conditions. The code in the treatment envelopes matched the code on the corresponding syringe. The preparation and administration of the medication were carried out by a nurse who had not been involved in the management of the patient except for drug administration. The placebo syringe contained saline 0.9%, similar in the amount and color to the lidocaine syringe. The surgeon who performed the cesarean delivery complied with the instruction included in the envelope, but was not further involved in data gathering or patient care.
Throughout the trial, access to the randomization code was only available to the secretary of the Statistics department who had performed the randomization and the coding of the envelopes and data sheets. Whether the participants received intraperitoneal placebo or lidocaine was concealed from residents and caregivers. The postoperative data collection was carried out for 24 hours by a resident physician who was not in charge of labor, and inquiries about pain were conducted by telephone 15 days later, and then every 2 weeks up to 8 months, if needed, by this same resident. The randomization code of the data sheets was not broken until the completion of the study.
Experimental Protocol
Cesarean section in most of the cases was carried out by the first author of this study and in the rest by 2 other obstetricians, with at least 2 years of obstetric experience. All have conducted at least 400 cesarean sections. Firstgeneration cephalosporin (cefazolin) was given at a dose of 1 g intravenously 20 minutes before skin incision. Cesarean section was carried out under spinal anesthesia. Anesthesia was delivered in most of the cases by the second author of this study and in the rest by 2 other anesthetists with a minimum of 2 years of experience, all have managed at least 400 cases. Skin was incised using the Pfannenstiel incision. The subcutaneous tissues were opened using the blunt mode, the anterior rectus sheath was opened sharply, and the rectus muscles were separated using the no cutting technique. After opening of the parietal peritoneum with sharp dissection and blunt expansion, high above the bladder, bladder flap development was performed. A small median transverse hysterotomy incision in the lower uterine segment was made using a scalpel, expanded on both sides and after delivery of the baby and the placenta, uterine closure, using continuous nonlocking double layer closure, without exteriorization was completed. Visceral peritoneum was left open in all patients. This was followed by closing the abdomen in layers. Parietal peritoneum was closed using continuous nonlocking sutures with delayed absorbable material. No approximation of rectus muscles was performed. As requested by the randomization code, patients received intraperitoneal instillation of either 10 cc of sterile saline (0.9%) (group 1) or 10 cc of lidocaine 2% (group 2) using a sterile syringe, so that the fluid is instilled into the pelvis. Care was taken that blood accumulating into the pelvis after closing the uterine incision and hematomas was carefully wiped out with surgical towels, leaving a more or less ''dry'' pelvis before the fluid was instilled. Closure of the subcutaneous tissue was done with single stitches. Closure of the skin was performed with an intracutaneous suture. No intra-abdominal, subrectal, or subcutaneous drains were left.
Postoperative Analgesia
Intravenous acetaminophen (perphalgan) of 1 gm was given every 6 hours for the first 36 hours. Rectal suppository of 10 mg ibuprofen followed by 400 mg orally every 4 to 6 hours were given for the first 72 hours. Intravenous morphine of 2 mg was used for breakthrough pain. Patients were monitored by caregivers for side effects of morphine injections such as nausea, vomiting, drowsiness, and itching.
Pain Scoring
All pain scores were obtained during rest. To assess pain on the first postoperative day, visual analog scoring (VAS) was used by means of a 10-cm line with verbal anchors saying ''no pain'' at 1 end and ''excruciating pain'' at the other end. Thereafter, a numerical rating score (NRS) was used. Two, 6, and 12 hours after surgery, VAS was performed to assess each of the following: global abdominal pain and pain in the epigastric region and at the wound site, and a mean pain score of each region was recorded. Fifteen days after surgery, NRSs were collected for pain at the same sites through telephone call. Patients with persistent pain after 15 days were further contacted through telephone every 15 days to record their NRS until pain disappearance or up to 8 months after surgery. Pain of any character was assessed for the 3 regions: wound, epigastric, and abdominal (global). Wound pain was defined as pain related to the incision; epigastric pain as pain related to the epigastric region; and abdominal pain as pain of an ill-defined site, and/or diffuse as to include more than 1 abdominal region.
Sample Size, Power, and Statistical Analysis
We relied on our previous published results, 4 comparing parietal closure and nonclosure as regards postcesarean pain, which we conducted in the same setting. We reported the incidence of first day postcesarean epigastric pain after parietal peritoneal closure to be approximately 27%. Assuming a 15% difference between both groups in our current study (control vs. lidocaine groups), the required sample size was 121 patients in each group. This was based on an 80% power of the study and a 95% confidence interval. We included 185 women in each group to account for follow-up losses and allow a proper subgroup analysis of patients who will present with persistent pain after 8 months. Data were analyzed using the SPSS version 13.0 (SPSS, Chicago, IL). The primary outcome was the score of epigastric pain on the first and fifteenth postoperative days. Epigastric pain was chosen because it is visceral, sitespecific pain, and therefore can be etiologically linked to peritoneal traction. Secondary outcomes included analgesic needs, and number of patients with pain on the first, fifteenth postoperative days, and persistent pain after 8 months, and also number of patients reporting 1 or more of the side effects related to morphine injections. Results were reported as mean ± standard deviation and percentages. The w 2 test or, if necessary, the Fisher exact test was used to compare continuous data, and VAS and NRS were compared using the Wilcoxon ranked sum test. P value of less than 0.05 was considered significant.
RESULTS
We assessed 881 patients for eligibility to participate in the study. Two hundred eighty-six patients were excluded because of not meeting the inclusion criteria, and 225 patients refused to participate. The remaining 370 patients were allocated to either group, group 1 (n = 185) and group 2 (n = 185). Sixteen patients were lost to follow-up and excluded from analysis. Of these patients, 9 were in the group 1 and 7 in the group 2. Figure 1 shows a flowchart of study including patients' enrollment, allocation, follow-up, and analysis. Both groups were comparable as regards demographic data of age (y), parity, and gestational age (wk). Indications of cesarean section were comparable in both groups ( Significantly more control patients reporting of wound pain on the first postoperative day, compared with lidocaine patients [35 (19.7%) vs. 10 (5.7%), P<0.001, Table 2 ]. Wound pain persisted more frequently up to 15 days in control group patients [24 (13.5%) vs. 13 (7.4%), P = 0.09, Table 2 ] and the need for seeking medical treatment was higher among these patients, compared with those in the lidocaine group [5 (2.8%) vs. 2 (1.1%), P = 0.25]. After 8 months, more patients from the control group reported wound pain [14 (7.9%) vs. 6 (3.4%), P<0.05, Table 2 ], only 1 patient from each group sought medical advice (P = 1.00).
Regarding abdominal pain scores, significantly higher global abdominal VAS on the first postoperative day was reported among control group patients when compared with lidocaine group patients (4.4 ± 1.4, vs. 2.8 ± 1.3, with a range of 2.0 to 7.0 in both groups, P<0.001) (Fig. 2) . Fifteen day postsurgery, the mean NRS for both groups was equal (3.9 ± 1.3 vs. 4.0 ± 1.1, with a range of 2.0 to 8.0 in both groups, P = 1.00, Fig. 2 ). After 8 months, controls had a significantly higher NRS (3.6 ± 1.8 vs. 2.3 ± 1.5, with a range of 2.0 to 5.0 in both groups, P<0.01) (Fig. 2) . Significantly higher epigastric VAS on the first postoperative day was reported among control group patients when compared with lidocaine group patients (5.9 ± 1.4, vs. 4.7 ± 0.9, with a range of 3.0 to 8.0 and 2.0 to 7.0, respectively, P<0.01) (Fig. 3) . Fifteen day postsurgery, the mean NRS was significantly higher among controls (3.8 ± 1.5 vs. 3.0 ± 1.2, with a range of 2.0 to 5.0 in both groups, P<0.01, Fig. 3 ). After 8 months, controls had a significantly higher NRS (4.3 ± 1.2 vs. 3.3 ± 1.1, with a range of 2.0 to 5.0 and 2.0 to 4.0, respectively, P<0.001, Fig. 3 ). Significantly higher wound pain VAS on the first postoperative day was reported among control group patients when compared with lidocaine group patients (4.6 ± 1.1 vs. 3.1 ± 1.5 with a range of 2.0 to 7.0 and 2.0 to 5.0, respectively, P<0.001, Fig. 4 ). Fifteen day postsurgery, the mean NRS for both groups was equal (2.3 ± 1.3 vs. 1.6 ± 1.2, with a range of 1.0 to 4.0 and 1.0 to 3.0, P<0.01, Fig. 4) . Eight months postsurgery, controls had a significantly higher NRS (0.9 ± 0.4 vs. 0.8 ± 0.5, with a range of 1.0 to 3.0 and 1.0 to 2.0, P = 0.92) (Fig. 4) .
Patients reporting pain 8 months after surgery had significantly lower pain scores on day 1, day 15, and 8 months after surgery when they received intraperitoneal lidocaine, compared with control patients (Table 3 ).
In the control group there were significantly more patients reporting VAS scores higher than 5 on the first postoperative day than lidocaine group (81 of 178, 45. 14 of 146 (9.6%), P = 0.95, respectively], the differences were not significant.
DISCUSSION
Stretching, suturing, and reapproximation of the peritoneum cause ischemia, which is the most important cause of postoperative pain. 15 To our knowledge, this is the first study to report the effect of intraperitoneal lidocaine instillation on postcesarean pain. Regarding the choice of the dose, we used the same dose of both 10, 16 who used intraperitoneal lidocaine splashed on the undersurface of the diaphragm or injected down the intraperitoneal drain at the end of laparoscopic surgery and before postlaparotomy drain removal, respectively. 10, 16 The outcomes were lower analgesic needs, postoperative VAS, 10 and postdrain removal median pain scores. 16 We found that the pain incidence and scoring, in all sites (epigastric, abdominal, and wound sites) in women who received lidocaine were more favorable than controls, with better effect on visceral, compared with somatic and/or parietal pain. The use of lidocaine was associated with a significant morphine sparing effect, as evident by significantly few patients requiring morphine injections, less morphine consumption, and less reported side effects in lidocaine group.
Our previous results 4 suggested that parietal peritoneal closure was responsible for the high persistent postcesarean pain incidence (25.5%) compared with nonclosure technique (10.4%). In this study, the incidence of persistent postcesarean pain after parietal peritoneal closure has dropped significantly from 20.8% to 10.8% when intraperitoneal lidocaine instillation was used. Earlier reports on postcesarean persistent pain shows the incidence to range from 5.9% in Danish women reporting daily significant chronic wound scar pain, 6 months after cesarean, 3 to an incidence of 17.8% of overall postcesarean pain (wound scar, epigastric, and global abdominal pains) in our setting. 4 The lack of modern and expensive acute pain services as patient-controlled analgesia in our limited resource obstetric setting, and potential racial differences with regard to pain threshold, may explain the relatively higher persistent pain incidence in both our previous 4 and current studies, compared with studies conducted on different patient races with better pain service fascilities. 3 We found better somatic (wound) pain element scores among lidocaine patients. This could be attributed to an indirect effect of lidocaine on the visceral element. Visceral pain might, through a central sensitizing effect, lead to magnified perception of the somatic pain element (wound site pain). This will be discussed below in more details. Another explanation would be the lower morphine consumption among lidocaine patients, resulting into less nausea, vomiting, itching, drowsiness, and earlier mobility, as evidenced by our results. This culminates into an overall better patient satisfaction, less depression and anxiety, and, consequently, better tolerability of the somatic pain element as well. Patients with higher levels of anxiety and depression experience increased pain scores. 17, 18 Visceral pain is more difficult to attenuate than muscle and skin pain when using morphine. The different pain physiology pathways among patients can lead to various responses to different analgesics. 19, 20 In both groups, a high VAS value (>5) was a predictor for higher pain scores and persistent pain on the fifteenth day and after 8 months, compared with patients with scores less than 5 on the first day. This finding was consistent with our previous study. 4 Recently, women with severe acute postpartum pain were found to have a 2.5-fold increased risk of persistent pain compared with those with mild postpartum pain. 21 The association of intraperitoneal lidocaine use with a significantly lower incidence of persistent pain in our study emphasizes the importance of the control of acute pain for the prevention of chronic pain. 22, 23 Animal studies suggested that spinal nociception and hypothalamic-pituitary-adrenal-axis activation caused by laparotomy in pigs can be attenuated by the use of infiltration and incisional local anesthetics before surgery. 24 The enhanced responsiveness of nociceptive neurons in the central nervous system has been termed ''central sensitization.'' 25 This takes place in the dorsal horn of the spinal cord, the brain stem, and the brain and is hypothesized to play the cardinal role in chronic somatic and visceral pain hypersensitivity. 26 After surgical manipulations, nociceptive input is amplified, and changes in sensory processing in the spinal cord occur. Consequently, central sensitization allows normal low-threshold A-b mechanoreceptors to produce pain. 23 A long-lasting imprint of acute pain could contribute to its transition to chronic pain. Moderateto-severe acute postoperative pain was predictor of chronic pain after herniorrhaphy, and accounted for nearly 20% of the risk of development of chronic postsurgical pain syndrome. 27 Pain on day 15 and persistent pain in our study could be attributed, at least in part, to the high day 1 pain scores and central sensitization development.
We conclude that intraperitoneal instillation of 200 mg of lidocaine decreased the incidence and scores of postcesarean section pain when the parietal peritoneum was sutured. Before it can be widely practiced, the value of lidocaine to relieve pain in patients where the peritoneum is left open, and its potential selective role in relieving epigastric and abdominal pain should be assessed by further studies. These should be conducted in a setting with superior acute pain control protocols, as patientcontrolled analgesia. 
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